How to make usage of the standardized EuroFlow 8-color protocols possible for instruments of different manufacturers.

A critical component of the EuroFlow standardization of leukemia/lymphoma immunophenotyping is instrument setup. Initially, the EuroFlow consortium developed a step-by-step standard operating protocol for instrument setup of ≥8-color flow cytometers that were available in 2006, when the EuroFlow activities started. Currently, there are 14 instruments from 9 manufacturers capable of 3-laser excitation and ≥8 color measurements. The specific adaptations required in the instrument set-up to enable them to acquire the standardized 8-color EuroFlow protocols are described here. Overall, all 14 instruments can be fitted with similar violet, blue and red lasers for simultaneous measurements of ≥8 fluorescent dyes. Since individual instruments differ both on their dynamic range (scale) and emission filters, it is not accurate to simply recalculate the target values to different scale, but adjustment of PMT voltages to a given emission filter and fluorochrome, is essential. For this purpose, EuroFlow has developed an approach using Type IIB (spectrally matching) particles to set-up standardized and fully comparable fluorescence measurements, in instruments from different manufacturers, as demonstrated here for the FACSCanto II, and Navios and MACSQuant flow cytometers. Data acquired after such adjustment on any of the tested cytometry platforms could be fully superimposed and therefore analyzed together. The proposed approach can be used to derive target values for any combination of spectrally distinct fluorochromes and any distinct emission filter of any new flow cytometry platform, which enables the measurement of the 8-color EuroFlow panels in a standardized way, by creating superimposable datafiles.

[1]  Jeremy Hancock,et al.  Establishment and validation of a standard protocol for the detection of minimal residual disease in B lineage childhood acute lymphoblastic leukemia by flow cytometry in a multi-center setting; , 2009, Haematologica.

[2]  M. van der Burg,et al.  Selection and validation of antibody clones against IgG and IgA subclasses in switched memory B-cells and plasma cells. , 2019, JIM - Journal of Immunological Methods.

[3]  Quentin Lecrevisse,et al.  Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia. , 2017, Blood.

[4]  A Schwartz,et al.  Standardizing flow cytometry: a classification system of fluorescence standards used for flow cytometry. , 1998, Cytometry.

[5]  N. Aghaeepour,et al.  Thinking outside the gate: single-cell assessments in multiple dimensions. , 2015, Immunity.

[6]  Alberto Orfao,et al.  Overview of clinical flow cytometry data analysis: recent advances and future challenges. , 2013, Trends in biotechnology.

[7]  U. Johansson,et al.  Guidelines on the use of multicolour flow cytometry in the diagnosis of haematological neoplasms , 2014, British journal of haematology.

[8]  Mario Roederer,et al.  Data File Standard for Flow Cytometry, version FCS 3.1 , 2009, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[9]  E S Costa,et al.  Automated pattern-guided principal component analysis vs expert-based immunophenotypic classification of B-cell chronic lymphoproliferative disorders: a step forward in the standardization of clinical immunophenotyping , 2010, Leukemia.

[10]  C. E. Pedreira,et al.  Quality assessment program for EuroFlow protocols: Summary results of four‐year (2010–2013) quality assurance rounds , 2015, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[11]  Barbara Buldini,et al.  Minimal residual disease analysis by eight-color flow cytometry in relapsed childhood acute lymphoblastic leukemia , 2015, Haematologica.

[12]  F. Lacombe,et al.  Comparable flow cytometry data can be obtained with two types of instruments, Canto II, and Navios. A GEIL study , 2013, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[13]  A Orfao,et al.  EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes , 2012, Leukemia.

[14]  M. Altfeld,et al.  Standardization of cytokine flow cytometry assays , 2005, BMC Immunology.

[15]  R. Brant,et al.  A standardized immune phenotyping and automated data analysis platform for multicenter biomarker studies. , 2018, JCI insight.

[16]  A Orfao,et al.  Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma , 2017, Leukemia.

[17]  T. Kalina,et al.  Frequent issues and lessons learned from EuroFlow QA. , 2018, Journal of immunological methods.

[18]  B. Palmer,et al.  In Vivo Blockade of the PD-1 Receptor Suppresses HIV-1 Viral Loads and Improves CD4+ T Cell Levels in Humanized Mice , 2013, The Journal of Immunology.

[19]  Next Generation Flow (NGF) for High Sensitive Detection of Minimal Residual Disease (MRD) in Multiple Myeloma (MM) , 2015 .

[20]  T. Kalina,et al.  EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols , 2012, Leukemia.

[21]  Greg Finak,et al.  OpenCyto: An Open Source Infrastructure for Scalable, Robust, Reproducible, and Automated, End-to-End Flow Cytometry Data Analysis , 2014, PLoS Comput. Biol..